- Named actives
- Tretinoin, niacinamide, vitamin C
- Price
- From $42 per month
- Concentrations
- Confirm the actual prescription
- Access
- Clinical assessment required
Consider the specific change being sought
Smooth Move is marketed for concerns that include fine lines, uneven tone and texture. Those concerns can overlap, but they are not one interchangeable treatment outcome.[source]
Describe the main concern to the prescriber: for example, fine surface lines versus a deeper expression line. A cream’s reasonable role should be explained in that context rather than framed as a promise to remove every visible sign of aging.
The public ingredient list is a starting point
Tretinoin is the prescription retinoid named in this blend. Niacinamide and vitamin C are also listed, but the public information reviewed does not establish a universal strength for each ingredient.
The dispensing label should resolve the actual preparation, instructions and storage requirements. It is also the right place to verify whether an ingredient that previously caused a reaction is present in the base, not just among the headline actives.
Use approved-drug evidence with its boundaries intact
RENOVA 0.02% is one example of an approved tretinoin product with a limited fine-wrinkle indication alongside comprehensive skincare and sun avoidance. Its label does not promise wrinkle elimination.[source]
That evidence helps frame realistic questions about tretinoin, but it does not establish approval or equivalent outcomes for Smooth Move. Compounded products are not reviewed by FDA before marketing in the same way as approved drugs.[source]
Resolve the plan before comparing its value
At the advertised starting figure, the useful buying questions are the full initial payment, amount supplied, follow-up access and renewal terms. Ask what happens if the formula needs changing before the next refill.[source]
The cream may be a candidate for a clinical discussion about fine lines. This review cannot select its strength for a reader or verify an outcome from personal use. The retail-versus-prescription guide explains the broader decision.
Your questions, answered
Does first place mean the cream won a clinical trial?
No. CoreAge Rx is the featured commercial partner. We have not verified a trial showing Smooth Move outperformed this selection.
Is Smooth Move the same as an approved tretinoin cream?
No equivalence is established here. The actual compounded prescription and its supporting evidence need to be assessed separately.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx: Smooth MoveOfficial source; checked October 8, 2026
- CoreAge Rx: products and plan termsOfficial source; checked October 8, 2026
- DailyMed: RENOVA 0.02% prescribing informationOfficial source; checked October 8, 2026
- FDA: compounding questions and answersOfficial source; checked October 8, 2026